Actavis UK Ltd

Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk
Medical Information Fax:

Patient Information Leaflet last updated on the eMC: 01/07/2011
PIL Neotigason 10mg & 25mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Change to warnings or special precautions for use
Updated on 07/01/2009 and displayed until 01/07/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to MA holder contact details
Updated on 12/09/2007 and displayed until 07/01/2009
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
Updated on 26/04/2007 and displayed until 12/09/2007
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 30/03/2006 and displayed until 26/04/2007
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 09/09/2004 and displayed until 30/03/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 13/12/2002 and displayed until 09/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/11/2001 and displayed until 13/12/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   acitretin